• 医学文献
  • 知识库
  • 评价分析
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
  • 临床诊疗知识库
  • 中医药知识库
  • 机构
  • 作者
热搜词:
换一批
论文 期刊
取消
高级检索

检索历史 清除

医学文献>>
  • 全部
  • 中外期刊
  • 学位
  • 会议
  • 专利
  • 成果
  • 标准
  • 法规
知识库 >>
  • 临床诊疗知识库
  • 中医药知识库
评价分析 >>
  • 机构
  • 作者
热搜词:
换一批

Impact of bortezomib-based versus lenalidomide maintenance therapy on outcomes of patients with high-risk multiple myeloma.

广告
第一作者: Naresh,Bumma
第一单位: James Cancer Center, Ohio State Medical Center, Columbus, Ohio, USA.
作者单位: James Cancer Center, Ohio State Medical Center, Columbus, Ohio, USA. [1] Bone Marrow Transplant and Cellular Therapy Program, Division of Hematology/Oncology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. [2] Division of Biostatistics, Institute for Health and Equity, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. [3] Center for International Blood and Marrow Transplant Research (CIBMTR), Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. [4] Dana-Farber Cancer Institute, Boston, Massachusetts, USA. [5] Bone Marrow Transplant Program, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA. [6] Markey Cancer Center, University of Kentucky, Lexington, Kentucky, USA. [7] Fred Hutchinson Cancer Research Center, Seattle, Washington, USA. [8] Division of Hematology/BMT, Kansas City Veterans Affairs Medical Center, Kansas City, Missouri, USA. [9] Department of Hematology, Royal Adelaide Hospital, Adelaide, South Australia, Australia. [10] Division of Transplantation and Cellular Therapy, University of Miami Hospital and Clinics, Sylvester Comprehensive Cancer Center, Miami, Florida, USA. [11] University Hospital Seidman Cancer Center, Case Western Reserve University, Cleveland, Ohio, USA. [12] Department of Oncology, McMaster University, Hamilton, Ontario, Canada. [13] Blood and Marrow Transplantation Program, Division of Hematology-Oncology, Mayo Clinic, Jacksonville, Florida, USA. [14] Section of Bone Marrow Transplant and Cell Therapy, Division of Hematology, Oncology, and Cell Therapy, Rush University Medical Center, Chicago, Illinois, USA. [15] Department of Blood and Marrow Transplant and Cellular Immunotherapy, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida, USA. [16] Transplant and Cellular Therapy Program, Huntsman Cancer Center Institute, University of Utah, Salt Lake City, Utah, USA. [17] The Blood and Marrow Transplant Group of Georgia, Northside Hospital, Atlanta, Georgia, USA. [18] Division of Hematology, Oncology, and Bone Marrow Transplantation, University of Iowa, Iowa City, Iowa, USA. [19] Jonn Theurer Cancer Center at Hackensack University Medical Center, Hackensack, New Jersey, USA. [20] Hematology/Oncology, Mayo Clinic, Rochester, Minnesota, USA. [21] Department of Blood and Marrow Transplantation, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA. [22] Division of Hematology-Oncology, University of California San Francisco, San Francisco, California, USA. [23] Division of Blood and Marrow Transplantation, Department of Medicine, Stanford Health Care, Stanford, California, USA. [24]
DOI 10.1002/cncr.34778
PMID 37021929
发布时间 2024-07-16
提交
  • 浏览4
Cancer

Cancer

2023年129卷14期

2179-2191页

相似文献

  • 中文期刊
  • 外文期刊
  • 学位论文
  • 会议论文

加载中!

加载中!

加载中!

加载中!

特别提示:本网站仅提供医学学术资源服务,不销售任何药品和器械,有关药品和器械的销售信息,请查阅其他网站。

  • 客服热线:4000-115-888 转3 (周一至周五:8:00至17:00)

  • |
  • 客服邮箱:yiyao@wanfangdata.com.cn

  • 违法和不良信息举报电话:4000-115-888,举报邮箱:problem@wanfangdata.com.cn,举报专区

官方微信
万方医学小程序
new翻译 充值 订阅 收藏 移动端

官方微信

万方医学小程序

使用
帮助
Alternate Text
调查问卷